The price of Healthcare Triangle Inc. (NASDAQ: HCTI) closed at $0.25 in the last session, up 8.72% from day before closing price of $0.23. In other words, the price has increased by $+0.0197 from its previous closing price. On the day, 1189657 shares were traded. HCTI stock price reached its highest trading level at $0.2700 during the session, while it also had its lowest trading level at $0.2260.
We take a closer look at HCTI’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 2.20 and its Current Ratio is at 2.20. In the meantime, Its Debt-to-Equity ratio is 0.14 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
For the stock, the TTM Price-to-Sale (P/S) ratio is 0.21 while its Price-to-Book (P/B) ratio in mrq is 0.50.
Stock Price History:
Over the past 52 weeks, HCTI has reached a high of $1.68, while it has fallen to a 52-week low of $0.11. The 50-Day Moving Average of the stock is 0.2033, while the 200-Day Moving Average is calculated to be 0.5618.
According to the various share statistics, HCTI traded on average about 2.46M shares per day over the past 3-months and 694.03k shares per day over the past 10 days. A total of 36.02M shares are outstanding, with a floating share count of 15.08M. Insiders hold about 63.77% of the company’s shares, while institutions hold 7.90% stake in the company. Shares short for HCTI as of Oct 13, 2022 were 95.08k with a Short Ratio of 0.16M, compared to 25.76k on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 0.24% and a Short% of Float of 0.74%.
The company has 1 analysts who recommend its stock at the moment. The consensus estimate for the next quarter is -$0.03, with high estimates of -$0.03 and low estimates of -$0.03.
Analysts are recommending an EPS of between -$0.16 and -$0.16 for the fiscal current year, implying an average EPS of -$0.16. EPS for the following year is -$0.12, with 1 analysts recommending between -$0.12 and -$0.12.
Based on 1 analysts’ estimates, the company’s revenue will be $55.9M in the next fiscal year. The high estimate is $55.9M and the low estimate is $55.9M. The average revenue growth estimate for next year is up 12.90% from the average revenue estimate for this year.